Cost Consequence Analysis Of Apixaban Versus Warfarin In Patients With Atrial Fibrillation In The Mexican Public Health Sector
Abstract
Authors
A. Juarez-Garcia B.M.K. Donato E. Muciño-Ortega A. Davila L. Guirant-Corpi
A. Juarez-Garcia B.M.K. Donato E. Muciño-Ortega A. Davila L. Guirant-Corpi
ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now